H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report) shares traded down 49.5% during mid-day trading on Thursday. The stock traded as low as $2.02 and last traded at $2.02. 400 shares changed hands during trading, an increase of 288% from the average daily volume of 103 shares. The stock had previously closed at $4.00.
H-CYTE Stock Down 49.5%
The company’s 50 day moving average price is $2.02 and its 200 day moving average price is $2.02.
H-CYTE Company Profile
H-CYTE, Inc is a medical technology company focused on developing and commercializing noninvasive therapeutic products based on photobiomodulation, a treatment approach that uses specific wavelengths of light to stimulate biological responses in the body.
The company’s principal product is the H-Cyte System, a light-based therapy platform designed for use by healthcare providers. The system has been promoted for applications involving chronic health conditions, including respiratory and pain-related disorders.
See Also
- Five stocks we like better than H-CYTE
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for H-CYTE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H-CYTE and related companies with MarketBeat.com's FREE daily email newsletter.
